戻る
European Commission Authorizes Eli Lilly's Kisunla for Early Alzheimer's Disease
戻る
株式ニュース
テーマ
European Commission Authorizes Eli Lilly's Kisunla for Early Alzheimer's Disease
ドナルド・トランプ
European Commission Authorizes Eli Lilly's Kisunla for Early Alzheimer's Disease
Edgen Stock
·
Sep 30 2025, 04:15
共有先
共有先
リンクをコピー
ソース：
[1] Eli Lilly Gets European Authorization for Alzheimer's Treatment
[2] Eli Lilly's (LLY) Alzheimer's Drug Kisunla Approved in Europe - GuruFocus
[3] Lilly's Kisunla (donanemab) and the Transformation of Alzheimer's Treatment - AInvest
Edgen Stock·Sep 30 2025, 04:15Edgen Stock·Sep 30 2025, 04:15
Edgen Stock·Sep 30 2025, 04:15